The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.
None
None
All adult HT recipients were consecutive prospectively enrolled who underwent transthoracic echocardiography for surveillance at their routine follow-up
Cohort
Prospective
Not listed
All cause death
All cause death after HT was obtained via telephone interview with family members; contact with his/her physicians; or hospital records
Major adverse cardiac events
Major adverse cardiac events after the inclusion of the study was obtained via telephone interview with family members; contact with his/her physicians; or hospital records
Click on the lead sponsor to view all of their trials.
Xie Mingxing
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Sponsor institution
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborator
Shanghai Zhongshan Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator
Wuhan Asia Heart Hospital
Collaborator
Guangdong Provincial People's Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
